---
title: "Addus HomeCare (NASDAQ:ADUS) Releases Quarterly  Earnings Results"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/239207946.md"
description: "Addus HomeCare (NASDAQ:ADUS) reported its quarterly earnings, posting an EPS of $1.29, missing estimates of $1.33. The company had a net margin of 6.50% and a return on equity of 9.62%. Revenue increased by 20.3% year-over-year. Despite the earnings miss, analysts maintain a positive outlook, with several upgrades and a consensus price target of $139.00. The stock traded down 0.6% to $104.37, with a market cap of $1.92 billion and a P/E ratio of 23.88."
datetime: "2025-05-07T22:06:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239207946.md)
  - [en](https://longbridge.com/en/news/239207946.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239207946.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/239207946.md) | [繁體中文](https://longbridge.com/zh-HK/news/239207946.md)


# Addus HomeCare (NASDAQ:ADUS) Releases Quarterly  Earnings Results

Addus HomeCare (NASDAQ:ADUS - Get Free Report) issued its quarterly earnings data on Monday. The company reported $1.42 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.33 by $0.09, Briefing.com reports. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. During the same period in the prior year, the company posted $1.21 EPS. The business's revenue was up 20.3% compared to the same quarter last year.

Get **Addus HomeCare** alerts:

## Addus HomeCare Trading Down 0.6 %

Shares of NASDAQ ADUS traded down $0.63 during trading on Monday, reaching $104.37. 221,340 shares of the company traded hands, compared to its average volume of 163,869. Addus HomeCare has a 12-month low of $88.96 and a 12-month high of $136.72. The stock has a market cap of $1.92 billion, a P/E ratio of 23.88, a PEG ratio of 1.41 and a beta of 0.85. The firm's fifty day simple moving average is $97.46 and its 200 day simple moving average is $114.99.

## Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. JMP Securities reiterated a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a report on Tuesday, April 22nd. Oppenheimer upped their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Stephens reiterated an "overweight" rating and issued a $142.00 target price on shares of Addus HomeCare in a research note on Wednesday, March 12th. Macquarie restated an "outperform" rating and set a $129.00 price target on shares of Addus HomeCare in a research note on Thursday, February 27th. Finally, StockNews.com downgraded shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, Addus HomeCare presently has a consensus rating of "Buy" and a consensus price target of $139.00.

**View Our Latest Stock Analysis on Addus HomeCare**

## Addus HomeCare Company Profile

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

## Featured Stories

-   Five stocks we like better than Addus HomeCare
-   What is an Earnings Surprise?
-   Monster Beverage Stock: Short Report Risks vs Upside Potential
-   How to invest in marijuana stocks in 7 steps
-   Onsemi Stock Confirms Bottom, But What’s the Upside?
-   What is the Australian Securities Exchange (ASX)
-   3 Tech Leaders Announce Buybacks Totaling $85 Billion

## Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

### 相关股票

- [Addus Homecare (ADUS.US)](https://longbridge.com/zh-CN/quote/ADUS.US.md)

## 相关资讯与研究

- [Addus HomeCare CFO Flags Medicaid Rate Outlook, Gentiva Deal Progress, and M&A Pipeline at Conference](https://longbridge.com/zh-CN/news/277677109.md)
- [Addus HomeCare (NASDAQ:ADUS) EVP Roberton James Stevenson Sells 567 Shares](https://longbridge.com/zh-CN/news/277119001.md)
- [Addus HomeCare Q4 adjusted EPS beats analyst expectations](https://longbridge.com/zh-CN/news/276646130.md)
- [A Look Ahead: Addus HomeCare's Earnings Forecast](https://longbridge.com/zh-CN/news/276462820.md)
- [Addus HomeCare Corporation $ADUS Stake Lifted by Renaissance Group LLC](https://longbridge.com/zh-CN/news/266749278.md)